BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23493327)

  • 1. Isolated microalbuminuria indicates a poor medical prognosis.
    Scheven L; Van der Velde M; Lambers Heerspink HJ; De Jong PE; Gansevoort RT
    Nephrol Dial Transplant; 2013 Jul; 28(7):1794-801. PubMed ID: 23493327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary albumin excretion at follow-up predicts cardiovascular outcomes in subjects with resistant hypertension.
    Oliveras A; Armario P; Sierra C; Arroyo JA; Hernández-del-Rey R; Vazquez S; Larrousse M; Sans L; Roca-Cusachs A; de la Sierra A
    Am J Hypertens; 2013 Sep; 26(9):1148-54. PubMed ID: 23747954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study.
    Soedamah-Muthu SS; Visseren FL; Algra A; van der Graaf Y;
    Diabet Med; 2008 Jan; 25(1):51-7. PubMed ID: 18199132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study.
    Sasso FC; Chiodini P; Carbonara O; De Nicola L; Conte G; Salvatore T; Nasti R; Marfella R; Gallo C; Signoriello S; Torella R; Minutolo R;
    Nephrol Dial Transplant; 2012 Jun; 27(6):2269-74. PubMed ID: 22090446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients.
    Viazzi F; Leoncini G; Conti N; Tomolillo C; Giachero G; Vercelli M; Deferrari G; Pontremoli R
    J Hypertens; 2010 Apr; 28(4):848-55. PubMed ID: 20087212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes.
    Ayala DE; Moyá A; Crespo JJ; Castiñeira C; Domínguez-Sardiña M; Gomara S; Sineiro E; Mojón A; Fontao MJ; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):99-115. PubMed ID: 23098178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combined contribution of albuminuria and glomerular filtration rate to the prediction of cardiovascular mortality in elderly men.
    Nerpin E; Ingelsson E; Risérus U; Sundström J; Larsson A; Jobs E; Jobs M; Hallan S; Zethelius B; Berglund L; Basu S; Arnlöv J
    Nephrol Dial Transplant; 2011 Sep; 26(9):2820-7. PubMed ID: 21335440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do albuminuria and hs-CRP add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome?
    van der Velde M; Bello AK; Brantsma AH; El Nahas M; Bakker SJ; de Jong PE; Gansevoort RT
    Nephrol Dial Transplant; 2012 Jun; 27(6):2275-83. PubMed ID: 22231032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microalbuminuria as a predictor of a drop in glomerular filtration rate in subjects with non-insulin-dependent diabetes mellitus and hypertension.
    Berrut G; Bouhanick B; Fabbri P; Guilloteau G; Bled F; Le Jeune JJ; Fressinaud P; Marre M
    Clin Nephrol; 1997 Aug; 48(2):92-7. PubMed ID: 9285145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toe-brachial index as a predictor of cardiovascular disease and all-cause mortality in people with type 2 diabetes and microalbuminuria.
    Zobel EH; von Scholten BJ; Reinhard H; Persson F; Hansen TW; Parving HH; Jacobsen PK; Rossing P
    Diabetologia; 2017 Oct; 60(10):1883-1891. PubMed ID: 28681124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of reduction in urinary albumin excretion to ten-year cardiovascular mortality in patients with type 2 diabetes and systemic hypertension.
    Estacio RO; Dale RA; Schrier R; Krantz MJ
    Am J Cardiol; 2012 Jun; 109(12):1743-8. PubMed ID: 22440125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic importance of baseline and serial changes in microalbuminuria in patients with resistant hypertension.
    Salles GF; Cardoso CR; Fiszman R; Muxfeldt ES
    Atherosclerosis; 2011 May; 216(1):199-204. PubMed ID: 21315356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
    Hermida RC; Ayala DE; Fernández JR; Mojón A
    Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular hypertrophy and diabetes.
    Ibsen H; Olsen MH; Wachtell K; Borch-Johnsen K; Lindholm LH; Mogensen CE
    J Nephrol; 2008; 21(4):566-9. PubMed ID: 18651547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP).
    McCullough PA; Jurkovitz CT; Pergola PE; McGill JB; Brown WW; Collins AJ; Chen SC; Li S; Singh A; Norris KC; Klag MJ; Bakris GL;
    Arch Intern Med; 2007 Jun; 167(11):1122-9. PubMed ID: 17563019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
    Donnelly R; Yeung JM; Manning G
    J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twelve shifting paradigms in diabetic renal disease and hypertension.
    Mogensen CE
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS).
    Jia W; Gao X; Pang C; Hou X; Bao Y; Liu W; Wang W; Zuo Y; Gu H; Xiang K
    Nephrol Dial Transplant; 2009 Dec; 24(12):3724-31. PubMed ID: 19617258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced GFR and microalbuminuria are independently associated with prevalent cardiovascular disease in Type 2 diabetes: JDDM study 16.
    Yokoyama H; Oishi M; Kawai K; Sone H;
    Diabet Med; 2008 Dec; 25(12):1426-32. PubMed ID: 19046241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney-protective effects of azelnidipine versus a diuretic in combination with olmesartan in hypertensive patients with diabetes and albuminuria: a randomized study.
    Kojima M; Okubo S; Mizubayashi R; Isaka N; Machida H; Okamoto S; Hirota H; Takeuchi M; Kato T; Nakatani K; Mizuno O; Miyagawa K; Makino K; Okura T; Dohi Y; Ito M; Kimura G
    Nephrol Dial Transplant; 2013 Jul; 28(7):1802-10. PubMed ID: 23535223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.